Roger Song
Stock Analyst at Jefferies
(0)
# 4951
Out of 5,328 analysts
48
Total ratings
29.03%
Success rate
-30.72%
Average return
Main Sectors:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
KNSA Kiniksa Pharmaceutic... | Maintains: Strong Buy | 40 45 | 28.03 | 60.54% | 2 | Apr 29, 2025 | |
NKTR Nektar Therapeutics | Upgrades: Buy | 1 2 | 0.78 | 156.41% | 8 | Apr 11, 2025 | |
AKBA Akebia Therapeutics | Initiates Coverage On: Buy | 6 | 2.4 | 150% | 1 | Apr 1, 2025 | |
SANA Sana Biotechnology | Initiates Coverage On: Buy | 7 | 1.91 | 266.49% | 1 | Mar 14, 2025 | |
KRYS Krystal Biotech | Initiates Coverage On: Buy | 245 | 165.92 | 47.66% | 1 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 26 | 7.96 | 226.63% | 1 | Feb 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 48 2 | 1.33 | 50.38% | 2 | Jan 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 42 7 | 4.13 | 69.49% | 2 | Dec 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 16 19 | 9.73 | 95.27% | 1 | Dec 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 32 28 | 6.46 | 333.44% | 2 | Nov 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 2 7 | 1.39 | 403.6% | 1 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 89 | 49.52 | 79.73% | 1 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 31 25 | 6.4 | 290.62% | 2 | Oct 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 41 | 11.32 | 262.19% | 1 | Oct 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 35 | 11.48 | 204.88% | 1 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 9 | 3.38 | 166.27% | 1 | Sep 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 108 129 | 35.28 | 265.65% | 1 | Sep 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 3 8 | 0.77 | 938.96% | 3 | May 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 97 | 77.3 | 25.49% | 1 | Apr 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 41 72 | 17.59 | 309.32% | 2 | Mar 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 110 | 28.73 | 282.88% | 1 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 31 2 | n/a | n/a | 2 | Sep 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 30 35 | 5.2 | 573.08% | 1 | Aug 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 9 | 0.93 | 867.74% | 1 | Jul 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 675 | n/a | n/a | 1 | Jan 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 8 | 3.5 | 128.57% | 2 | Dec 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 3 4 | 0.26 | 1438.46% | 2 | Nov 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 30 | n/a | n/a | 1 | Feb 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 315 | n/a | n/a | 1 | Sep 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 21 | 1.04 | 1919.23% | 1 | Sep 2, 2020 |